Skip to main navigation Skip to search Skip to main content

Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery

  • on behalf of the N3C Consortium
  • Medical College of Wisconsin

Research output: Contribution to journalComment/debate

5 Scopus citations
Original languageEnglish
Pages (from-to)1305-1308
Number of pages4
JournalAnnals of Surgical Oncology
Volume30
Issue number3
DOIs
StatePublished - Mar 2023

Fingerprint

Dive into the research topics of 'Vaccination Against SARS-CoV-2 Decreases Risk of Adverse Events in Patients who Develop COVID-19 Following Cancer Surgery'. Together they form a unique fingerprint.

Cite this